A Systematic Review of the Literature Examining the Effects of Cigarette Smoke and e-Cigarette Vapor on the Virulence of Human Pathogenic Bacteria.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
30 09 2022
Historique:
received: 22 08 2022
revised: 22 09 2022
accepted: 28 09 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

The bioactive chemicals in cigarette smoke (CS) and e-cigarette vapor (EV) may affect pathogenic bacteria in the nasopharyngeal microflora, which may have implications on the pathophysiology of respiratory infections in cigarette smokers and e-cigarette users. In this systematic review, we seek to synthesize the research evidence supporting this hypothesis. To address the central research question, "

Identifiants

pubmed: 36231813
pii: ijerph191912518
doi: 10.3390/ijerph191912518
pmc: PMC9565164
pii:
doi:

Substances chimiques

E-Cigarette Vapor 0
Reactive Oxygen Species 0
Nicotine 6M3C89ZY6R

Types de publication

Journal Article Review Systematic Review Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : R21AI165939
Pays : United States

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Infect Immun. 2012 Nov;80(11):3804-11
pubmed: 22890993
Infect Immun. 2009 Jan;77(1):335-40
pubmed: 18955475
J Infect. 2020 Feb;80(2):204-209
pubmed: 31669377
Emerg Infect Dis. 2002 Sep;8(9):881-90
pubmed: 12194761
Infect Immun. 2015 Jun;83(6):2443-52
pubmed: 25824841
J Public Health Policy. 2011 Feb;32(1):16-31
pubmed: 21150942
J Immunol. 2017 Aug 1;199(3):1170-1183
pubmed: 28667160
Environ Health Perspect. 2016 Jun;124(6):733-9
pubmed: 26642857
J Mol Med (Berl). 2016 Jun;94(6):667-79
pubmed: 26804311
Am J Prev Med. 2018 Jun;54(6):831-841
pubmed: 29656920
Thorax. 2012 Oct;67(10):908-13
pubmed: 22550083
Chest. 2015 Nov;148(5):1307-1322
pubmed: 26135024
Sci Rep. 2019 Dec 27;9(1):20243
pubmed: 31882881
Sci Rep. 2018 Oct 24;8(1):15716
pubmed: 30356075
Oral Dis. 2021 Apr;27(3):639-647
pubmed: 32683796
BMC Microbiol. 2014 Sep 30;14:253
pubmed: 25266973
Am J Respir Cell Mol Biol. 2016 Oct;55(4):586-601
pubmed: 27253086
Ann Am Thorac Soc. 2016 Sep;13(9):1615-23
pubmed: 27348071
Environ Microbiol. 2009 May;11(5):1242-53
pubmed: 19175666
J Appl Microbiol. 2022 May;132(5):3951-3958
pubmed: 35187773
PLoS One. 2010 May 04;5(5):e9323
pubmed: 20454607
Microb Genom. 2020 Dec;6(12):
pubmed: 33295863
Annu Rev Genet. 2008;42:541-64
pubmed: 18713030
Infect Immun. 2020 Oct 19;88(11):
pubmed: 32868344
Eur Respir J. 2013 Feb;41(2):392-5
pubmed: 22743667
J Microbiol. 2012 Feb;50(1):143-8
pubmed: 22367949
Sci Rep. 2019 Jul 25;9(1):10798
pubmed: 31346202
PLoS Pathog. 2008 Apr 25;4(4):e1000052
pubmed: 18437240
J Infect Chemother. 2020 Dec;26(12):1278-1282
pubmed: 32800691
Eur Respir J. 2018 Feb 7;51(2):
pubmed: 29437942
J Periodontal Res. 2012 Dec;47(6):766-75
pubmed: 22712587
Respir Res. 2019 Dec 18;20(1):267
pubmed: 31847850
PLoS One. 2011 Jan 06;6(1):e15700
pubmed: 21253587
Appl Environ Microbiol. 2020 Jan 21;86(3):
pubmed: 31791951
Crit Rev Toxicol. 2020 Feb;50(2):97-127
pubmed: 32043402
Int J Environ Res Public Health. 2011 Feb;8(2):613-28
pubmed: 21556207
PLoS One. 2021 Nov 15;16(11):e0259895
pubmed: 34780570
Annu Rev Microbiol. 2003;57:677-701
pubmed: 14527295
J Allergy Clin Immunol Pract. 2022 Jul 21;:
pubmed: 35872217
FEMS Immunol Med Microbiol. 1999 Jan;23(1):27-36
pubmed: 10030544
Biomed Res Int. 2014;2014:976347
pubmed: 25013815
Arch Oral Biol. 2009 Nov;54(11):1061-7
pubmed: 19712925

Auteurs

Kamal Bagale (K)

Department of Biology, University of Louisiana at Lafayette, Lafayette, LA 70504, USA.

Ritwij Kulkarni (R)

Department of Biology, University of Louisiana at Lafayette, Lafayette, LA 70504, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH